Atopic Keratoconjunctivitis: Diagnosis and Treatment

AbstractPurpose of ReviewThis review aims to provide an update on the diagnosis and the latest management options for atopic keratoconjunctivitis (AKC).Recent FindingsAtopic keratoconjunctivitis (AKC) is a chronic, inflammatory condition seen in patients with atopic dermatitis at any point during the disease course. It is the most severe type of allergic eye disease and can have potentially severe ocular sequelae leading to blindness. Recent additions to the armamentarium for the treatment of severe atopic disease have focused on steroid sparing agents that include systemic T cell and calcineurin inhibitor medications as well as novel drug delivery systems.SummaryOcular involvement in atopic disease includes the periorbita and eyelids, conjunctiva, and cornea. Progressive disease can lead to blindness, especially in younger patients with more severe disease. Effective management of this condition requires a multidisciplinary approach, including dermatology, allergy and immunology, and ophthalmology.
Source: Current Ophthalmology Reports - Category: Opthalmology Source Type: research